心臟衰竭软体市场：按交付形式和部署划分 - 2025-2030 年全球预测

2023年心臟衰竭软体市场规模为32.4亿美元，预计2024年将达到34.7亿美元，复合年增长率为7.02%，到2030年将达到52.2亿美元。

心臟衰竭软体市场包括旨在帮助医疗保健提供者管理、诊断和治疗心臟衰竭的数位解决方案。这些软体工具对于追踪患者健康指标、促进及时介入和改善整体治疗结果至关重要。临床医生可以透过处理复杂的资料集、监测趋势和个人化治疗计划来提高心臟衰竭管理的有效性。该软体的应用涵盖病患监测、电子健康记录管理、药物管理和预测分析等领域。最终使用者范围主要包括医院、诊所、研究所、心臟医疗中心等。由于生活方式的改变、人口老化和医疗保健IT基础设施的进步，心臟衰竭衰竭的盛行率日益增加，推动了市场的成长。此外，远端医疗的普及和对远端患者监护日益增长的需求对于推动市场向前发展至关重要。人工智慧主导分析的进一步发展、穿戴式装置的整合以及增强即时资料可存取性的云端基础的解决方案的扩展都存在机会。然而，挑战仍然存在，包括资料隐私问题、监管合规问题以及开发和维护先进软体基础设施的高成本。创新的最佳方向是互通性，增强预测演算法，并培育使用者友善的介面以广泛传播给临床医生。市场研究应着重于增加患者共同管理工具并透过扩大医疗基础设施来开拓区域市场。市场竞争温和，特点是科技公司与医疗保健提供者之间的合作、策略性收购以及持续投资研发以推动技术进步。透过优先考虑与新技术相容的扩充性解决方案并专注于最终用户的综合培训计划，公司可以最大限度地减少采用新系统的阻力并优化成长。

市场动态：揭示快速发展的心臟衰竭软体市场的关键市场洞察

供需的动态交互作用正在改变心臟衰竭软体市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

• 市场驱动因素
  • 郁血性心臟衰竭增加
  • 不健康的生活方式和心臟相关疾病的增加
  • 世界人口老化和家庭照护的成长趋势
• 市场限制因素
  • 高价导致的负担能力问题
• 市场机会
  • 先进监控系统的出现
  • 倾向于智慧型和可携式监控系统
• 市场挑战
  • 消费者认知度低

波特五力：驾驭心臟衰竭软体市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解心臟衰竭软体市场的外部影响

外部宏观环境因素在塑造心臟衰竭软体市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解心臟衰竭软体市场的竞争格局

心臟衰竭软体市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵心臟衰竭软体市场供应商的绩效评估

FPNV 定位矩阵是评估心臟衰竭软体市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了心臟衰竭软体市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对心臟衰竭软体市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

• 市场动态
  • 促进因素
    • 郁血性心臟衰竭的发生率增加
    • 不健康的生活方式和心臟病相关疾病的增加
    • 世界各地的人口正在老化，家庭照护的趋势正在增加。
  • 抑制因素
    • 高价造成负担能力问题
  • 机会
    • 先进监控系统的出现
    • 智慧型和可携式监控系统的趋势
  • 任务
    • 消费者认知度低
• 市场区隔分析
• 波特五力分析
• PESTEL分析
  • 政治的
  • 经济
  • 社群
  • 技术的
  • 合法地
  • 环境

第六章以交付方式分類的心臟衰竭软体市场

• 知识库
• 非知识基础

第七章心臟衰竭软体市场：依部署

• 云端基础
• 本地

第八章美洲心臟衰竭软体市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第九章亚太心臟衰竭软体市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第十章欧洲、中东和非洲心臟衰竭软体市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第十一章竞争格局

• 2023 年市场占有率分析
• FPNV 定位矩阵，2023
• 竞争情境分析
• 战略分析和建议

公司名单

• 4S Information Systems Ltd.
• Abbott Laboratories
• Axis Clinical Software, Inc.
• Cerner Corporation by Oracle Corporation
• CitiusTech Inc.
• CV Medical Software
• Handicare Group by Savaria
• Medtronic PLC
• PulseCheck by Harris Healthcare Group
• Vuno
• Zoll Medical Corporation

The Heart Failure Software Market was valued at USD 3.24 billion in 2023, expected to reach USD 3.47 billion in 2024, and is projected to grow at a CAGR of 7.02%, to USD 5.22 billion by 2030.

The heart failure software market encompasses digital solutions designed to assist healthcare providers in managing, diagnosing, and treating heart failure. These software tools are essential in tracking patient health metrics, facilitating timely interventions, and improving overall care outcomes. They enable clinicians to process complex datasets, monitor trends, and personalize treatment plans, thereby enhancing the efficacy of heart failure management. The application of this software spans areas such as patient monitoring, electronic health record management, medication management, and predictive analytics. End-user scope primarily includes hospitals, clinics, research institutions, and specialized cardiac care centers. Market growth is driven by the increasing prevalence of heart failure due to lifestyle changes, an aging population, and advances in healthcare IT infrastructure. Additionally, the growing adoption of telemedicine and the need for remote patient monitoring are crucial in propelling the market forward. Opportunities arise in further developing AI-driven analytics, integrating wearable devices, and expanding cloud-based solutions that enhance real-time data accessibility. Nonetheless, challenges persist, such as data privacy concerns, regulatory compliance issues, and the high costs of developing and maintaining advanced software infrastructures. Innovations are best directed towards improving interoperability with existing healthcare systems, enhancing predictive algorithms, and fostering user-friendly interfaces to ensure widespread adoption among clinicians. Market research should focus on increasing patient co-management tools and exploring regional markets with expanding healthcare infrastructure. The heart failure software market is moderately competitive, characterized by collaborations between tech firms and healthcare providers, strategic acquisitions, and ongoing investments in research and development to drive technological advancements. Firms can optimize growth by prioritizing scalable solutions ensuring compatibility with emerging technologies and focusing on comprehensive training programs for end-users to minimize resistance to adopting new systems.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Heart Failure Software Market

The Heart Failure Software Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growth in incidences of congestive heart failure
  • Adoption of unhealthy lifestyle and increasing heart related diseases
  • Growth in aging population across the globe and rising home care trend
• Market Restraints
  • High price creating affordability issues
• Market Opportunities
  • Emergence of advanced monitoring systems
  • Inclination towards smart and portable monitoring systems
• Market Challenges
  • Limited awareness among consumers

Porter's Five Forces: A Strategic Tool for Navigating the Heart Failure Software Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Heart Failure Software Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Heart Failure Software Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Heart Failure Software Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Heart Failure Software Market

A detailed market share analysis in the Heart Failure Software Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Heart Failure Software Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Heart Failure Software Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Heart Failure Software Market

A strategic analysis of the Heart Failure Software Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Heart Failure Software Market, highlighting leading vendors and their innovative profiles. These include 4S Information Systems Ltd., Abbott Laboratories, Axis Clinical Software, Inc., Cerner Corporation by Oracle Corporation, CitiusTech Inc., CV Medical Software, Handicare Group by Savaria, Medtronic PLC, PulseCheck by Harris Healthcare Group, Vuno, and Zoll Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Heart Failure Software Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Delivery Mode, market is studied across Knowledge-Based and Non-Knowledge Based.
• Based on Deployment, market is studied across Cloud-Based and On-Premises.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growth in incidences of congestive heart failure
    • 5.1.1.2. Adoption of unhealthy lifestyle and increasing heart related diseases
    • 5.1.1.3. Growth in aging population across the globe and rising home care trend
  • 5.1.2. Restraints
    • 5.1.2.1. High price creating affordability issues
  • 5.1.3. Opportunities
    • 5.1.3.1. Emergence of advanced monitoring systems
    • 5.1.3.2. Inclination towards smart and portable monitoring systems
  • 5.1.4. Challenges
    • 5.1.4.1. Limited awareness among consumers
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Heart Failure Software Market, by Delivery Mode

• 6.1. Introduction
• 6.2. Knowledge-Based
• 6.3. Non-Knowledge Based

7. Heart Failure Software Market, by Deployment

• 7.1. Introduction
• 7.2. Cloud-Based
• 7.3. On-Premises

8. Americas Heart Failure Software Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Heart Failure Software Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Heart Failure Software Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 4S Information Systems Ltd.
• 2. Abbott Laboratories
• 3. Axis Clinical Software, Inc.
• 4. Cerner Corporation by Oracle Corporation
• 5. CitiusTech Inc.
• 6. CV Medical Software
• 7. Handicare Group by Savaria
• 8. Medtronic PLC
• 9. PulseCheck by Harris Healthcare Group
• 10. Vuno
• 11. Zoll Medical Corporation

LIST OF FIGURES

• FIGURE 1. HEART FAILURE SOFTWARE MARKET RESEARCH PROCESS
• FIGURE 2. HEART FAILURE SOFTWARE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. HEART FAILURE SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. HEART FAILURE SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HEART FAILURE SOFTWARE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HEART FAILURE SOFTWARE MARKET DYNAMICS
• TABLE 7. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY KNOWLEDGE-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY NON-KNOWLEDGE BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 16. ARGENTINA HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 18. BRAZIL HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 20. CANADA HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 21. CANADA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 22. MEXICO HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 24. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 27. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. AUSTRALIA HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 32. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 33. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 34. INDIA HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 35. INDIA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 36. INDONESIA HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 38. JAPAN HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 40. MALAYSIA HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 42. PHILIPPINES HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 44. SINGAPORE HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 46. SOUTH KOREA HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 48. TAIWAN HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 50. THAILAND HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 52. VIETNAM HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. DENMARK HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 59. EGYPT HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 61. FINLAND HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 63. FRANCE HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 65. GERMANY HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 67. ISRAEL HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 69. ITALY HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 70. ITALY HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 71. NETHERLANDS HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 73. NIGERIA HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 75. NORWAY HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 77. POLAND HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 78. POLAND HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 79. QATAR HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 80. QATAR HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 81. RUSSIA HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 83. SAUDI ARABIA HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 87. SPAIN HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 89. SWEDEN HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 91. SWITZERLAND HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 93. TURKEY HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 95. UNITED ARAB EMIRATES HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 97. UNITED KINGDOM HEART FAILURE SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 99. HEART FAILURE SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 100. HEART FAILURE SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023